At the start of March, the New Hampshire General Court resumed its sessions post a weeklong winter recess, aligning with school district holidays. The focus now shifts to meeting imminent “crossover” deadlines, crucial for bills to move from their chamber of origin to the other. The Senate’s deadline is March 27, followed by the House’s on April 10. Post these dates, both legislative bodies will continue discussions on active bills until late June.
Additionally, lawmakers are tasked with approving a new state budget. In mid-February, Governor Ayotte presented her two-year budget plan, which prioritizes efficiency, cost reduction, and avoids new taxes. The proposed budget allocates $16.5 billion for the upcoming two years, an increase from the previous $15.2 billion. “NFIB NH applauded the governor’s focus on fiscal responsibility and hopes that lawmakers can find room to continue the successful business tax cuts of the Sununu years.”
Governor Ayotte is optimistic about a speedy recovery in business tax revenue, projecting a smaller deficit of $81 million against other estimates of $113 million. However, some legislators anticipate a broader deficit and reduced revenue, expecting first-quarter tax payments to provide clearer insight.
Regarding legislation, several bills are under review and have encountered opposition from NFIB NH. Among them are workers’ compensation (HB 299), employment mandates (HB 378 and HB 487), and proposed increases in unemployment insurance payouts (HB 542). Bills addressing business tax reforms (HB 503), minimum wage adjustments (SB 176), and other employment-related legislations (SB 246, referred to as “Momnibus 2.0”) are also under scrutiny. “SB 246,” in particular, poses a new precedent for businesses employing fewer than 50 employees, with NFIB NH citing potential infringement on employer-employee relations. Despite objections, the committee’s recommendation was “Out to Pass (OTP).”
On the other hand, NFIB NH supports SB 256 regarding Pharmacy Benefit Managers, co-authored with Sen. Tim McGough. The bill aims to ensure patient access to necessary medications is prioritized, balancing cost-saving measures and timely drug administration primarily in low-cost settings, except in emergencies.
